Glaucoma management after vitreoretinal surgeries

Helen Kornmann, Steven J Gedde

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Purpose of review The surgical management of retinal disorders, including scleral buckling procedures, pars plana vitrectomy, and intravitreal injections of gas or silicone oil, can lead to short-Term elevations in intraocular pressure (IOP) and ultimately long-Term glaucomatous damage if not treated in a timely manner. Glaucoma in these cases is commonly refractory to conventional therapies. This review highlights the treatment strategies for glaucoma in eyes that have previously undergone vitreoretinal surgery. Recent findings Although medical therapy is often used initially to control a temporary rise in IOP, laser and surgical therapy may be required to treat sustained IOP elevation and subsequent glaucomatous damage in eyes that have undergone intraocular surgery for retinal disorders. Glaucoma drainage devices are an important treatment modality, particularly when there is high risk of failure with filtering surgery. Summary Previous vitreoretinal surgery is a known risk factor for the development of glaucoma. Treatment is usually initiated with medical therapy, however, surgical intervention is frequently required to control IOP and prevent progressive glaucomatous damage in patients with refractory glaucoma.

Original languageEnglish (US)
Pages (from-to)125-131
Number of pages7
JournalCurrent Opinion in Ophthalmology
Volume27
Issue number2
DOIs
StatePublished - Mar 1 2016

Fingerprint

Vitreoretinal Surgery
Glaucoma
Intraocular Pressure
Therapeutics
Scleral Buckling
Filtering Surgery
Silicone Oils
Intravitreal Injections
Temazepam
Vitrectomy
Laser Therapy
Drainage
Gases
Equipment and Supplies

Keywords

  • glaucoma
  • medical and surgical management
  • vitreoretinal surgery

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Glaucoma management after vitreoretinal surgeries. / Kornmann, Helen; Gedde, Steven J.

In: Current Opinion in Ophthalmology, Vol. 27, No. 2, 01.03.2016, p. 125-131.

Research output: Contribution to journalArticle

@article{375673189b4f4b0681c3a9a0c1813364,
title = "Glaucoma management after vitreoretinal surgeries",
abstract = "Purpose of review The surgical management of retinal disorders, including scleral buckling procedures, pars plana vitrectomy, and intravitreal injections of gas or silicone oil, can lead to short-Term elevations in intraocular pressure (IOP) and ultimately long-Term glaucomatous damage if not treated in a timely manner. Glaucoma in these cases is commonly refractory to conventional therapies. This review highlights the treatment strategies for glaucoma in eyes that have previously undergone vitreoretinal surgery. Recent findings Although medical therapy is often used initially to control a temporary rise in IOP, laser and surgical therapy may be required to treat sustained IOP elevation and subsequent glaucomatous damage in eyes that have undergone intraocular surgery for retinal disorders. Glaucoma drainage devices are an important treatment modality, particularly when there is high risk of failure with filtering surgery. Summary Previous vitreoretinal surgery is a known risk factor for the development of glaucoma. Treatment is usually initiated with medical therapy, however, surgical intervention is frequently required to control IOP and prevent progressive glaucomatous damage in patients with refractory glaucoma.",
keywords = "glaucoma, medical and surgical management, vitreoretinal surgery",
author = "Helen Kornmann and Gedde, {Steven J}",
year = "2016",
month = "3",
day = "1",
doi = "10.1097/ICU.0000000000000238",
language = "English (US)",
volume = "27",
pages = "125--131",
journal = "Current Opinion in Ophthalmology",
issn = "1040-8738",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Glaucoma management after vitreoretinal surgeries

AU - Kornmann, Helen

AU - Gedde, Steven J

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Purpose of review The surgical management of retinal disorders, including scleral buckling procedures, pars plana vitrectomy, and intravitreal injections of gas or silicone oil, can lead to short-Term elevations in intraocular pressure (IOP) and ultimately long-Term glaucomatous damage if not treated in a timely manner. Glaucoma in these cases is commonly refractory to conventional therapies. This review highlights the treatment strategies for glaucoma in eyes that have previously undergone vitreoretinal surgery. Recent findings Although medical therapy is often used initially to control a temporary rise in IOP, laser and surgical therapy may be required to treat sustained IOP elevation and subsequent glaucomatous damage in eyes that have undergone intraocular surgery for retinal disorders. Glaucoma drainage devices are an important treatment modality, particularly when there is high risk of failure with filtering surgery. Summary Previous vitreoretinal surgery is a known risk factor for the development of glaucoma. Treatment is usually initiated with medical therapy, however, surgical intervention is frequently required to control IOP and prevent progressive glaucomatous damage in patients with refractory glaucoma.

AB - Purpose of review The surgical management of retinal disorders, including scleral buckling procedures, pars plana vitrectomy, and intravitreal injections of gas or silicone oil, can lead to short-Term elevations in intraocular pressure (IOP) and ultimately long-Term glaucomatous damage if not treated in a timely manner. Glaucoma in these cases is commonly refractory to conventional therapies. This review highlights the treatment strategies for glaucoma in eyes that have previously undergone vitreoretinal surgery. Recent findings Although medical therapy is often used initially to control a temporary rise in IOP, laser and surgical therapy may be required to treat sustained IOP elevation and subsequent glaucomatous damage in eyes that have undergone intraocular surgery for retinal disorders. Glaucoma drainage devices are an important treatment modality, particularly when there is high risk of failure with filtering surgery. Summary Previous vitreoretinal surgery is a known risk factor for the development of glaucoma. Treatment is usually initiated with medical therapy, however, surgical intervention is frequently required to control IOP and prevent progressive glaucomatous damage in patients with refractory glaucoma.

KW - glaucoma

KW - medical and surgical management

KW - vitreoretinal surgery

UR - http://www.scopus.com/inward/record.url?scp=84956926606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956926606&partnerID=8YFLogxK

U2 - 10.1097/ICU.0000000000000238

DO - 10.1097/ICU.0000000000000238

M3 - Article

VL - 27

SP - 125

EP - 131

JO - Current Opinion in Ophthalmology

JF - Current Opinion in Ophthalmology

SN - 1040-8738

IS - 2

ER -